Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-538-4 | CAS number: -
No ADME studies concerning toxicokinetics are available for the registration substance. However, structure related consideration suggests enzymatic degradation in analogy to accepted metabolic pathways for amide hydrolysis and fatty acid ß-oxidation. The assumed metabolism will not generate metabolites of toxicological concern. Excretion of postulated final metabolic products is considered fast and complete. Due to its solid state, the low water solubility, the moderate molecular weight close to 500 and the ionic nature, only reduced dermal penetration is anticipated.
Experimental data on toxicokinetics of the registration substance is not available. From structur relationship considerations, it is anticipated that this compound is absorbed from the gastro-intestinal tract. An absorption rate of 100% is therefore assumed by default. Inhalation exposure is assumed to be equivalent to oral exposure. Due to its solid state, the low water solubility of < 100 microgram per liter, the moderate molecular weight close to 500 and the ionic nature, dermal penetration of the substance is considered to be low in accordance with REACH Guidance (R7.12). An absorption rate of 20% is taken which is in line with an exposure assessment carried out by the US EPA on the registration substance during the establishment of an exemption from the requirement of a tolerance for residues of `sodium N-oleyl-N-methyl taurine` [EPA-HQ-OPP-2008 -075; FRL-8426 -8]. Following accepted metabolic pathways for alkylamides, it can be concluded that degradation of the registration substance sodium oleylmethyltauride by amide hydrolysis and fatty acid ß-oxidation take place. The initial step involves hydrolysis of the amide linkage to generate fatty acid and sodium N-methyltauride by fatty acid amide hydrolase (FAAH, EC 188.8.131.52), the principal catabolic enzyme for fatty acid amides having both, esterase and amidase activity. The resulting anionic sulfonate may be either directly excreted in the urine or converted to a dianionic salt with glucuronic acid that is excreted. The remaining fatty acid is metabolized in a second step via the ß-oxidation pathway. Metabolites of toxicological significance are not to be expected. This metabolic behaviour was demonstrated for sodium N-oleoyl-N-methyltaurine in
Pseudomonas alcaligenes (Denger et al. 2008).
As a conclusion from the available data, no conspicuous toxicokinetic behaviour is attributable to the registration substance. For assessment purposes, a value of 100% for oral uptake and a value of 20% is taken as conservative assumption for dermal penetration. Rapid and complete metabolism is anticipated with no resulting metabolites of significant toxicological concern. A bioaccumulation potential can be excluded.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again